AAPG Competitors & Alternatives
Compare Ascentage Pharma Group International with similar stocks in the same industry
Biotechnology
AAPG
Main Stock$16.46
Tradestie Score
39
Market Cap
$3.68B
Revenue Growth
0.3%
Analyst Upside
+186.3%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$45.29
|
$1.63B | - | 47 | Compare |
|
BHVN
Biohaven Ltd.
|
$12.74
|
$1.57B | - | 46 | Compare |
|
VCEL
Vericel Corporation
|
$39.38
|
$1.56B | 80.6 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$108.43
|
$1.55B | - | 56 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$41.91
|
$1.55B | 13.5 | 43 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$39.77
|
$1.55B | - | 49 | Compare |
|
NVAX
Novavax Inc
|
$9.53
|
$1.54B | - | 46 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.27
|
$1.50B | 7.1 | 53 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$38.35
|
$1.50B | - | 30 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$33.35
|
$1.49B | - | 44 | Compare |
More AAPG Analysis
Data updated: Sep 14, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry